219 related articles for article (PubMed ID: 38652741)
1. Decorin suppresses tumor lymphangiogenesis: A mechanism to curtail cancer progression.
Mondal DK; Xie C; Pascal GJ; Buraschi S; Iozzo RV
Proc Natl Acad Sci U S A; 2024 Apr; 121(18):e2317760121. PubMed ID: 38652741
[TBL] [Abstract][Full Text] [Related]
2. Decorin suppresses tumor lymphangiogenesis: A mechanism to curtail cancer progression.
Mondal DK; Xie C; Buraschi S; Iozzo RV
bioRxiv; 2023 Aug; ():. PubMed ID: 37693608
[TBL] [Abstract][Full Text] [Related]
3. Detection of lymphangiogenesis in non-small cell lung cancer and its prognostic value.
Sun JG; Wang Y; Chen ZT; Zhuo WL; Zhu B; Liao RX; Zhang SX
J Exp Clin Cancer Res; 2009 Feb; 28(1):21. PubMed ID: 19216806
[TBL] [Abstract][Full Text] [Related]
4. Intraocular tumor-associated lymphangiogenesis a novel prognostic factor for ciliary body melanomas with extraocular extension?
Heindl LM; Hofmann TN; Adler W; Knorr HL; Holbach LM; Naumann GO; Kruse FE; Cursiefen C
Ophthalmology; 2010 Feb; 117(2):334-42. PubMed ID: 19892405
[TBL] [Abstract][Full Text] [Related]
5. Platelet interaction with lymphatics aggravates intestinal inflammation by suppressing lymphangiogenesis.
Sato H; Higashiyama M; Hozumi H; Sato S; Furuhashi H; Takajo T; Maruta K; Yasutake Y; Narimatsu K; Yoshikawa K; Kurihara C; Okada Y; Watanabe C; Komoto S; Tomita K; Nagao S; Miura S; Hokari R
Am J Physiol Gastrointest Liver Physiol; 2016 Aug; 311(2):G276-85. PubMed ID: 27313177
[TBL] [Abstract][Full Text] [Related]
6. Suppression of lymphangiogenesis by soluble vascular endothelial growth factor receptor-2 in a mouse lung cancer model.
Maehana S; Nakamura M; Ogawa F; Imai R; Murakami R; Kojima F; Majima M; Kitasato H
Biomed Pharmacother; 2016 Dec; 84():660-665. PubMed ID: 27697638
[TBL] [Abstract][Full Text] [Related]
7. Docetaxel facilitates lymphatic-tumor crosstalk to promote lymphangiogenesis and cancer progression.
Harris AR; Perez MJ; Munson JM
BMC Cancer; 2018 Jul; 18(1):718. PubMed ID: 29976154
[TBL] [Abstract][Full Text] [Related]
8. The potential lymphangiogenic effects of hepatocyte growth factor/scatter factor in vitro and in vivo.
Jiang WG; Davies G; Martin TA; Parr C; Watkins G; Mansel RE; Mason MD
Int J Mol Med; 2005 Oct; 16(4):723-8. PubMed ID: 16142411
[TBL] [Abstract][Full Text] [Related]
9. Decorin protein core affects the global gene expression profile of the tumor microenvironment in a triple-negative orthotopic breast carcinoma xenograft model.
Buraschi S; Neill T; Owens RT; Iniguez LA; Purkins G; Vadigepalli R; Evans B; Schaefer L; Peiper SC; Wang ZX; Iozzo RV
PLoS One; 2012; 7(9):e45559. PubMed ID: 23029096
[TBL] [Abstract][Full Text] [Related]
10. Fucoxanthin inhibits tumour-related lymphangiogenesis and growth of breast cancer.
Wang J; Ma Y; Yang J; Jin L; Gao Z; Xue L; Hou L; Sui L; Liu J; Zou X
J Cell Mol Med; 2019 Mar; 23(3):2219-2229. PubMed ID: 30648805
[TBL] [Abstract][Full Text] [Related]
11. Retinal VEGF-A Overexpression Is Not Sufficient to Induce Lymphangiogenesis Regardless of VEGF-C Upregulation and Lyve1+ Macrophage Infiltration.
Wada I; Nakao S; Yamaguchi M; Kaizu Y; Arima M; Sawa S; Sonoda KH
Invest Ophthalmol Vis Sci; 2021 Oct; 62(13):17. PubMed ID: 34673901
[TBL] [Abstract][Full Text] [Related]
12. Relationship between cyclooxygenase-2 and human epidermal growth factor receptor 2 in vascular endothelial growth factor C up-regulation and lymphangiogenesis in human breast cancer.
Bhattacharjee RN; Timoshenko AV; Cai J; Lala PK
Cancer Sci; 2010 Sep; 101(9):2026-32. PubMed ID: 20608938
[TBL] [Abstract][Full Text] [Related]
13. Podoplanin-Expressing Macrophages Promote Lymphangiogenesis and Lymphoinvasion in Breast Cancer.
Bieniasz-Krzywiec P; Martín-Pérez R; Ehling M; García-Caballero M; Pinioti S; Pretto S; Kroes R; Aldeni C; Di Matteo M; Prenen H; Tribulatti MV; Campetella O; Smeets A; Noel A; Floris G; Van Ginderachter JA; Mazzone M
Cell Metab; 2019 Nov; 30(5):917-936.e10. PubMed ID: 31447322
[TBL] [Abstract][Full Text] [Related]
14. Aberrant lymphatic endothelial progenitors in lymphatic malformation development.
Wu JK; Kitajewski C; Reiley M; Keung CH; Monteagudo J; Andrews JP; Liou P; Thirumoorthi A; Wong A; Kandel JJ; Shawber CJ
PLoS One; 2015; 10(2):e0117352. PubMed ID: 25719418
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of tumor-associated lymphangiogenesis in malignant melanomas of the conjunctiva.
Heindl LM; Hofmann-Rummelt C; Adler W; Bosch JJ; Holbach LM; Naumann GO; Kruse FE; Cursiefen C
Ophthalmology; 2011 Dec; 118(12):2351-60. PubMed ID: 21835473
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of lymphangiogenesis and angiogenesis in breast tumor xenografts and lymph nodes by a peptide derived from transmembrane protein 45A.
Lee E; Koskimaki JE; Pandey NB; Popel AS
Neoplasia; 2013 Feb; 15(2):112-24. PubMed ID: 23441126
[TBL] [Abstract][Full Text] [Related]
17. The lymphatic system in clinically localized urothelial carcinoma of the bladder: morphologic characteristics and predictive value.
Bolenz C; Auer M; Ströbel P; Heinzelbecker J; Schubert C; Trojan L
Urol Oncol; 2013 Nov; 31(8):1606-14. PubMed ID: 22503575
[TBL] [Abstract][Full Text] [Related]
18. [Morphogenesis, structure and properties of lymphatic vessels].
Ratajska A; Jankowska-Steifer E; Czarnowska E; Flaht A; Radomska-Leśniewska D
Postepy Hig Med Dosw (Online); 2012 Nov; 66():901-12. PubMed ID: 23175346
[TBL] [Abstract][Full Text] [Related]
19. Proteoglycan neofunctions: regulation of inflammation and autophagy in cancer biology.
Schaefer L; Tredup C; Gubbiotti MA; Iozzo RV
FEBS J; 2017 Jan; 284(1):10-26. PubMed ID: 27860287
[TBL] [Abstract][Full Text] [Related]
20. Podoplanin+ tumor lymphatics are rate limiting for breast cancer metastasis.
Chen Y; Keskin D; Sugimoto H; Kanasaki K; Phillips PE; Bizarro L; Sharpe A; LeBleu VS; Kalluri R
PLoS Biol; 2018 Dec; 16(12):e2005907. PubMed ID: 30592710
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
